Dual-Mechanism Drop Wins FDA Approval - Poll - MDSpire

Dual-Mechanism Drop Wins FDA Approval

FDA approves Tenpoint Therapeutics’ YUVEZZI eye drop for presbyopia

  • February 2, 2026

  • 2 min

Share

Original Source(s)

Dual-Mechanism Drop Wins FDA Approval

  • February 2, 2026

Related Content

Success and Failure Rates with Increased-Range-of-Focus IOLs 

IRoF lenses offer high success, with some outperforming others

FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia

Deseyne delivers smooth, continuous focus across near, intermediate, and distance vision, which is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner.

Presbyopia Drops, a Promising Solution

While over-the-counter, prescription corrective lenses, and surgical interventions have been the mainstays of presbyopia management, presbyopia drops offer a non-invasive alternative.